Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
27 hedge funds and large institutions have $84.2M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.
111% more call options, than puts
Call options by funds: $697K | Put options by funds: $331K
50% more capital invested
Capital invested by funds: $56M → $84.2M (+$28.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
16% less funds holding
Funds holding: 32 → 27 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.48M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$1.42M |
| 3 |
Renaissance Technologies
New York
|
+$353K |
| 4 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
+$298K |
| 5 |
DMK
David M. Knott
|
+$211K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.21M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$819K |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$288K |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$90.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$77.6K |
CORV Hedge Fund Activity: Q2 2017 in Review
27 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2017, worth a combined $84.2M — up 50% from $56M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CORV and 2 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 11 added.
The largest buyer was Putnam Investments, adding an estimated $3.48M. The largest seller was Stonepine Capital Management, cutting an estimated $4.21M.
- 27 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2017, down from 32 in Q1 2017.
- Funds reported $84.2M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2017, up 50% quarter-over-quarter.
- 2 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2017 and 7 closed out, a net change of -5 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q2 2017 was Putnam Investments, an estimated $3.48M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q2 2017 was Stonepine Capital Management, an estimated $4.21M sold.
Based on aggregated 13F filings for Q2 2017.